Total Payments
$3,854
2024 Payments
$789.63
Companies
24
Transactions
181
Medicare Patients
15,641
Medicare Billing
$10.3M
Payment Breakdown by Category
Food & Beverage$3,854 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,854 | 181 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $940.74 | 42 | $0 (2024) |
| Alimera Sciences, Inc. | $651.10 | 27 | $0 (2024) |
| Genentech USA, Inc. | $577.13 | 39 | $0 (2024) |
| Allergan, Inc. | $208.39 | 14 | $0 (2021) |
| EyePoint Pharmaceuticals US, Inc. | $189.72 | 2 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $172.82 | 10 | $0 (2021) |
| ABBVIE INC. | $144.59 | 7 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $129.87 | 6 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $123.28 | 7 | $0 (2021) |
| Oyster Point Pharma, Inc. | $118.38 | 5 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $789.63 | 30 | Regeneron Healthcare Solutions, Inc. ($290.54) |
| 2023 | $788.42 | 29 | Regeneron Healthcare Solutions, Inc. ($261.39) |
| 2022 | $554.11 | 29 | Regeneron Healthcare Solutions, Inc. ($114.41) |
| 2021 | $331.47 | 19 | Alimera Sciences, Inc. ($101.77) |
| 2020 | $36.23 | 3 | Alimera Sciences, Inc. ($20.50) |
| 2019 | $392.94 | 23 | Novartis Pharmaceuticals Corporation ($124.57) |
| 2018 | $503.95 | 29 | Genentech USA, Inc. ($144.72) |
| 2017 | $457.22 | 19 | Regeneron Healthcare Solutions, Inc. ($185.90) |
All Payment Transactions
181 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $26.46 | General |
| Category: Ophthalmology | ||||||
| 12/15/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Ophthalmology | ||||||
| 11/22/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: OPTOMETRY | ||||||
| 11/13/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: EYE CARE | ||||||
| 10/30/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: Immunology and Ophthalmology | ||||||
| 10/04/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: OPHTHALMOLOGY | ||||||
| 09/16/2024 | Medtronic, Inc. | DEXTILE (Device) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Hernia Repair | ||||||
| 09/06/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 09/05/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $16.58 | General |
| Category: Immunology and Ophthalmology | ||||||
| 08/09/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 08/01/2024 | Genentech, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $26.86 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/27/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: OPHTHALMOLOGY | ||||||
| 07/23/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Immunology and Ophthalmology | ||||||
| 07/18/2024 | ABBVIE INC. | OZURDEX (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: EYE CARE | ||||||
| 07/17/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/25/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $20.96 | General |
| Category: OPHTHALMOLOGY | ||||||
| 06/24/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 05/14/2024 | Genentech USA, Inc. | Vabysmo (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Immunology and Ophthalmology | ||||||
| 04/30/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: OPHTHALMOLOGY | ||||||
| 04/23/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA HD (Biological) | Food and Beverage | In-kind items and services | $19.87 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/26/2024 | Alimera Sciences, Inc. | YUTIQ (Drug), ILUVIEN | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Treatment of chronic non-infectious uveitis affecting the posterior segment of the eye | ||||||
| 03/19/2024 | Regeneron Healthcare Solutions, Inc. | EYLEA (Biological) | Food and Beverage | In-kind items and services | $27.29 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 18 | 4,196 | 37,454 | $6.9M | $2.7M |
| 2022 | 16 | 4,075 | 15,265 | $5.9M | $2.5M |
| 2021 | 19 | 3,936 | 10,801 | $5.7M | $2.5M |
| 2020 | 18 | 3,434 | 10,574 | $5.7M | $2.5M |
Total Patients
15,641
Total Services
74,094
Medicare Billing
$10.3M
Procedure Codes
71
All Medicare Procedures & Services
71 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 215 | 1,928 | $2.8M | $1.3M | 47.0% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2023 | 111 | 27,910 | $2.2M | $810,361 | 36.4% |
| 67028 | Injection of drug into eye | Office | 2023 | 389 | 1,456 | $534,995 | $137,702 | 25.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2023 | 34 | 683 | $409,800 | $123,462 | 30.1% |
| 92134 | Imaging of retina | Office | 2023 | 1,014 | 2,474 | $247,400 | $77,806 | 31.4% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 852 | 861 | $129,150 | $75,328 | 58.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 220 | 416 | $99,850 | $40,710 | 40.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 353 | 577 | $86,550 | $39,047 | 45.1% |
| 92250 | Photography of the retina | Office | 2023 | 728 | 786 | $98,250 | $22,679 | 23.1% |
| 67040 | Destruction of eye fluid (vitreous) between lens and retina and all of retina using a laser | Facility | 2023 | 18 | 22 | $49,500 | $18,917 | 38.2% |
| 67041 | Removal of membrane of retina | Facility | 2023 | 11 | 11 | $27,300 | $10,536 | 38.6% |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | Facility | 2023 | 11 | 11 | $27,100 | $10,170 | 37.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 66 | 66 | $18,150 | $8,332 | 45.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 76 | 76 | $13,680 | $7,599 | 55.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 36 | 85 | $13,400 | $5,609 | 41.9% |
| 67145 | Photocoagulation treatment to prevent detachment of retina | Office | 2023 | 18 | 18 | $19,820 | $3,399 | 17.2% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 27 | 47 | $16,920 | $1,995 | 11.8% |
| 76512 | 2d ultrasound scan of eye tissue and structures | Office | 2023 | 17 | 27 | $4,600 | $993.43 | 21.6% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 234 | 2,196 | $3.2M | $1.6M | 48.7% |
| J2778 | Injection, ranibizumab, 0.1 mg | Office | 2022 | 62 | 1,284 | $770,400 | $289,583 | 37.6% |
| J2777 | Injection, faricimab-svoa, 0.1 mg | Office | 2022 | 46 | 4,980 | $398,400 | $148,610 | 37.3% |
| 67028 | Injection of drug into eye | Office | 2022 | 360 | 1,432 | $524,275 | $132,632 | 25.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 838 | 859 | $128,850 | $74,948 | 58.2% |
| 92134 | Imaging of retina | Office | 2022 | 937 | 2,335 | $233,500 | $72,671 | 31.1% |
| J3590 | Unclassified biologics | Office | 2022 | 23 | 28 | $136,400 | $49,553 | 36.3% |
About Dr. Michael Ward, MD
Dr. Michael Ward, MD is a Retina Specialist healthcare provider based in West Chester, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1609919406.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ward, MD has received a total of $3,854 in payments from pharmaceutical and medical device companies, with $789.63 received in 2024. These payments were reported across 181 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($3,854).
As a Medicare-enrolled provider, Ward has provided services to 15,641 Medicare beneficiaries, totaling 74,094 services with total Medicare billing of $10.3M. Data is available for 4 years (2020–2023), covering 71 distinct procedure/service records.
Ad
Practice Information
- Specialty Retina Specialist
- Other Specialties Ophthalmology
- Location West Chester, PA
- Active Since 02/14/2007
- Last Updated 10/10/2020
- Taxonomy Code 207WX0107X
- Entity Type Individual
- NPI Number 1609919406
Products in Payments
- EYLEA (Biological) $498.69
- YUTIQ (Drug) $480.75
- Lucentis (Biological) $411.84
- OZURDEX (Drug) $302.44
- ILUVIEN (Drug) $270.37
- EYLEA AFLIBERCEPT INJECTION (Biological) $233.39
- EYLEA HD (Biological) $208.66
- Vabysmo (Drug) $198.83
- TYRVAYA (Drug) $118.38
- AcrySof (Device) $111.16
- Cequa (Drug) $94.16
- Iluvien (Drug) $89.70
- XIIDRA (Drug) $83.11
- VYZULTA (Drug) $77.95
- ULTRA (Device) $49.95
- BEOVU (Drug) $46.39
- TRAVATAN Z (Drug) $39.86
- XIPERE (Drug) $37.70
- VABYSMO (Drug) $35.77
- LUMIGAN (Drug) $27.05
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.